Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Myriam Cleeren"'
Autor:
Timothy Devos, Tatjana Geukens, Alexander Schauvlieghe, Kevin K. Ariën, Cyril Barbezange, Myriam Cleeren, Veerle Compernolle, Nicolas Dauby, Daniël Desmecht, David Grimaldi, Bart N. Lambrecht, Anne Luyten, Piet Maes, Michel Moutschen, Marta Romano, Lucie Seyler, Michel Toungouz Nevessignsky, Katleen Vandenberghe, Johan van Griensven, Geert Verbeke, Erika Vlieghe, Jean Cyr Yombi, Laurens Liesenborghs, Peter Verhamme, Geert Meyfroidt
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-15 (2020)
Abstract Background The COVID-19 pandemic has imposed an enormous burden on health care systems around the world. In the past, the administration of convalescent plasma of patients having recovered from SARS and severe influenza to patients actively
Externí odkaz:
https://doaj.org/article/e2c17a0f94ae4fa2bd3259accdd55070
Autor:
Timothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, Kevin K. Ariën, Cyril Barbezange, Myriam Cleeren, Veerle Compernolle, Nicolas Dauby, Daniël Desmecht, David Grimaldi, Bart N. Lambrecht, Anne Luyten, Piet Maes, Michel Moutschen, Marta Romano, Lucie Seyler, Michel Toungouz Nevessignsky, Katleen Vandenberghe, Johan van Griensven, Geert Verbeke, Erika Vlieghe, Jean Cyr Yombi, Laurens Liesenborghs, Peter Verhamme, Geert Meyfroidt
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/30aec88a445e44dab92599746ef9197f
Autor:
Anne Luyten, Geert Verbeke, David Grimaldi, Michel Moutschen, Marta Romano, Cyril Barbezange, Michel Toungouz Nevessignsky, Veerle Compernolle, Daniel Desmecht, Geert Meyfroidt, Jean-Cyr Yombi, Peter Verhamme, Johan van Griensven, Lucie Seyler, Bart N. Lambrecht, Alexander Schauwvlieghe, Tatjana Geukens, Kevin K. Ariën, Katleen Vandenberghe, Myriam Cleeren, Timothy Devos, Erika Vlieghe, Nicolas Dauby, Laurens Liesenborghs, Piet Maes
Publikováno v:
TRIALS
Trials, Vol. 21, no.1, p. 981 [1-15] (2020)
Trials
Trials, 21 (1
Trials, Vol 21, Iss 1, Pp 1-15 (2020)
Trials, Vol. 21, no.1, p. 981 [1-15] (2020)
Trials
Trials, 21 (1
Trials, Vol 21, Iss 1, Pp 1-15 (2020)
Background The COVID-19 pandemic has imposed an enormous burden on health care systems around the world. In the past, the administration of convalescent plasma of patients having recovered from SARS and severe influenza to patients actively having th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb1f49de495d999ebc8d52579103a94
https://biblio.vub.ac.be/vubir/(904d7a29-317f-4fe8-8952-19fbee924d52).html
https://biblio.vub.ac.be/vubir/(904d7a29-317f-4fe8-8952-19fbee924d52).html
Autor:
Ronald Van Der Geest, Myriam Cleeren, Robert Wostenborghs, Achiel Van Hoof, Johan Maertens, Karel De Beule, Jean-Louis Michaux, Marc Boogaerts, André Bosly
Publikováno v:
Antimicrobial agents and chemotherapy, Vol. 45, no.3, p. 981-5 (2001)
The pharmacokinetics and safety of an intravenous hydroxypropyl-β-cyclodextrin solution of itraconazole administered for 7 days followed by itraconazole oral solution administered at 200 mg once or twice daily for 14 days were assessed in 17 patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4acd2ea9286f7152c4873d8ce6014ff4
https://pubmed.ncbi.nlm.nih.gov/11181397
https://pubmed.ncbi.nlm.nih.gov/11181397